Placenta Market Size, Share, Growth, and Industry Analysis, By Type (Ovine, Porcine, Equine & Others), By Application (Cosmetics, Health Tonics & Others) and Regional Forecast to 2033

PLACENTA MARKET REPORT OVERVIEW

Placenta Market Size was estimated at USD 79.7 million in 2024 and it is expected to grow from USD 85.84 million in 2025 to USD 99.57 million by 2033. The Market CAGR (growth rate) is expected to be around 7.7% during the forecast period (2025 - 2033).

On the back of demand for placental products in therapeutics and cosmetics, the placenta market expands enormously. Placental extracts find enhanced application in skincare products, pharmaceuticals, and supplements due to their regenerative and anti-aging features. The growth of the market is boosted by raised consumer awareness of the benefits brought about by placenta ingredients and innovative extraction technologies at work. Association of key players of the industry into research and development increases quality and efficacy, hence further providing impetus to market growth.

The Asia-Pacific region, especially Japan and China, dominates the placenta market. Companies from these regions are the innovators and producers. As consumers continue to seek officious and more sustainable products, the demand for more natural and bio-based products never stops rising. In a word, the placenta market keeps developing. Enormous opportunities exist out there by companies attaching importance to state-of-the-art technology and quality products.

• • 

    Request a Free sample to learn more about this report.

COVID-19 Impact: supply chain disruptions led to slowed market growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic affected the placenta market negatively. This is attributed to the fact that the pandemic had a negative impact on the global supply chain and on the manufacture of products. The outbreak caused interruptions to sourcing of raw materials and henceforth the production process. Lockdowns implemented coupled with travel restrictions delayed sourcing of raw materials and affected production, hence delaying products, hence making them less available. Operational challenges faced by the companies due to the economic downturn decreased further, reducing consumer spending on non-essential placental-based products. All these factors have plunged several companies into distress and uncertainty within the market.

LATEST TRENDS

"Advanced extraction technologies have led to enhanced product purity"

The most current trends in the placenta market growth is the companies emphasize on advanced extraction technologies to improve the effectiveness and purity of the final product. The working interest goes toward the demand for sustainable, natural, and bio-based products, backed by the increase in health consciousness of consumers. The companies invest heavily in research and development for new therapeutic and cosmetic applications. In addition, growing demand for personal care and wellness products in favor of placenta extracts. Geographical, Asia-Pacific, primarily Japan, and China, continues to be the market leader in generating a substantial amount of product innovation and increasing production capacity.

PLACENTA MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into ovine, porcine, equine & others.

• Ovine (Sheep): High protein and nutrients, and is most commonly used for products claimed to be skin regenerative.

• Porcine (Pig): Same as human placenta, it is used for health supplements and regenerative medicine.

• Equine (Horse): High growth factors content, it is considered as a luxury ingredient for high-end cosmetics.

• Others: Comprising bovine and marine sources, used for niche and specialized applications

By Application

Based on application the global market can be categorized into cosmetics, health tonics & others.

• Cosmetics: For anti-aging or skin renewal beauty products. It is increasingly favored on the back of the natural ingredient trend.

• Health Tonics: Used in health and vigor supplements; rising interest in wellness.

• Others: Includes medical and pharmaceutical applications, for advanced treatments and therapies.

DRIVING FACTORS

"Rising demand for natural and bioactive ingredients boost market growth"

A significant driving factor for the placenta market growth is the increase in demand coming from natural and bioactive ingredients. There is an increased reach of consumers for products that are natural, effective, and eco-friendly. A trend within cosmetics and health markets today is to use natural ingredients, viewed as safe and able to improve product effectiveness. Placental extracts, with regenerative and anti-aging properties, fit within this demand. These are now high-end skin products used more by health-conscious consumers in a bid to seek a place for bioactive and sustainably sourced ingredients.

"Advancements in extraction and processing technologies promote market expansion"

The development of technologies in the market for the extraction and processing of placental materials has also evolved for better quality and effectiveness. They include improved approaches to extraction, better preservation, and purification processes to ensure that placental extract retains the bioactive properties but in a more secure and potent manner. These improvements make placental products more versatile and appealing in various applications of advanced cosmetics and therapeutic solutions, hence drive growth in the market.

RESTRAINING FACTORS

"Regulatory and Ethical Concerns may restrain market growth"

There are a few major challenges attributed to the placenta market, such as stringent regulatory requirements and ethical reasons. Placentas are highly regulated materials because most countries have strict regulations regarding their use and processing in the interest of keeping track of safety and preventing misuse. Together, these two factors continue to hamper market growth because ethical concerns, specifically in relation to sourcing and animal welfare, are paramount in importance. Compliance to these regulatory policies, however, will raise the price as compared to the different factors that influence the products of the placental market.

• • 

    Request a Free sampleto learn more about this report.

PLACENTA MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"Asia-Pacific dominates global market share due to advancement in research and development "

The Asia-Pacific market has led the placenta market share, with countries like Japan and China following suit, because of strong advanced research and development capabilities, extensive manufacturing infrastructure, and high consumer demand. Japan is home to high-quality placental products that are used in premium cosmetics and health supplements. Equally, China has a very big plant and currently grows in its focus on health and wellness products. The central focus of this region on innovation combined with growing awareness among consumers regarding the benefits of placental extracts is driving this part of the world to a vanguard position in the worldwide market.

KEY INDUSTRY PLAYERS

"Key industry players drive markets by focusing on growth and innovation"

Enter your text here. Key industry players in the placenta market are making significant efforts to drive growth and innovation. Thus they are pumping millions into research and development in improving extraction and processing technologies for better pampering purity and effectiveness of the placental products. The companies are also going broader toward a range of applications from advanced skin care formulations to health supplements. This is complemented by stringent involvements of activity concerning regulatory requirements and ethical issues to guarantee product safety and sustainability. These, in particular, enable them to gain competitive advantage in the run-to run after livelier consumers' demand for natural and bioactive ingredients.

List of Market Players Profiled

• Japan Bio Products (Japan)
• Charites Japan (Japan)
• Japan Natural Laboratories (Japan)
• Bovogen Biologicals (Australia)
• Thimba Li (China)
• Agri-Lab Co-Products (United States)
• Yinchuan Yibaisheng (China)
• BIOFAC (Denmark)
• Hokkaido Natural Bio Group (Japan)
• Shaanxi Jintai Biological Engineering (China)
• Genesis Biolaboratory (United States)

INDUSTRIAL DEVELOPMENT

March 2024: Japan Bio Products announces it has developed a new, advanced extraction technology in regard to placental tissue. Thus, the extracts are purer and more active, and, hence, it firms Japan Bio Products in an international position in the placenta market not only with improved quality but also improved potency.

REPORT COVERAGE

An increased search for natural and bioactive ingredients, combined with the development of extraction technologies, is highly driving the growth of the placenta market. In the last few years, exponential growth in demand for placental products was observed in cosmetics and health supplements. Asia-Pacific dominated this market, driven by Japan and China, as it held strong R&D and manufacturing capabilities. Though key players in the market are under several challenges due to regulatory and ethical concerns, they remain focused on aspects of innovation and compliance to improve quality and make a difference in the market. Recent upgrades related to progressive extraction technologies are therefore likely to support their market positions and further improve the prospects for growth.